$艾切托(ACET.US)$Adicet Bio Highlights Preclinical Data Supporting Ind Readiness for Adi-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (Asgct) 27TH Annual Meeting. Preclinical Findings Showed Robust Anti-Tumor Activity of Adi-270 in Multiple Cd70-Positive Solid and Hematological Cancer Models
$艾切托(ACET.US)$Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares 7 MINUTES AGO, 4:01 PM EST VIA BUSINESSWIRE
艾切托股票討論區
Dow Jones· 5 mins ago
7 MINUTES AGO, 4:01 PM EST
VIA BUSINESSWIRE
Analysts monitoring Adicet Bio come to a price target consensus of $14.75
暫無評論